Turn Biotechnologies Sharpens Immunology Focus by Adding Two Cell Therapy Specialists to its Medical Advisory Board

MOUNTAIN VIEW, Calif., April 13, 2023 /PRNewswire/ — Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines for untreatable, age-related conditions, announced the appointment of two preeminent physicians to the company’s Medical Advisory Board. Memorial Sloan…